Cytek Biosciences, Inc. Common Stock CTKB
$4.89
+2.30%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | Insider transaction | 2026-08-12 | View → |
| 10-Q | 10-Q | 2026-08-05 | View → |
| 8-K | 8-K | 2026-08-05 | View → |
| 8-K | 8-K | 2026-07-15 | View → |
| 8-K | 8-K | 2026-06-25 | View → |
| 4 | Insider transaction | 2026-06-16 | View → |
| 8-K | 8-K | 2026-06-16 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 8-K | 8-K | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-05-20 | View → |
| 4 | Insider transaction | 2026-05-20 | View → |
| 4 | Insider transaction | 2026-05-20 | View → |
| 4 | Insider transaction | 2026-05-20 | View → |
| 4 | Insider transaction | 2026-05-20 | View → |
| 4 | Insider transaction | 2026-05-20 | View → |
| 4 | Insider transaction | 2026-05-20 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-07 | View → |
| DEF 14A | DEF 14A | 2026-04-28 | View → |
| 4 | Insider transaction | 2026-03-13 | View → |
| 4 | Insider transaction | 2026-03-12 | View → |
| 4 | Insider transaction | 2026-03-12 | View → |
| 4 | Insider transaction | 2026-03-12 | View → |
| 4 | Insider transaction | 2026-03-12 | View → |
| 4 | Insider transaction | 2026-03-12 | View → |
| 4 | Insider transaction | 2026-03-12 | View → |
| 4 | Insider transaction | 2026-03-12 | View → |
| 10-K | 10-K | 2026-02-26 | View → |
| 8-K | 8-K | 2026-02-26 | View → |
| 4 | Insider transaction | 2026-02-20 | View → |
| 4 | Insider transaction | 2026-02-20 | View → |
| 4 | Insider transaction | 2026-02-20 | View → |
| 8-K | 8-K | 2026-01-13 | View → |
| 4 | Insider transaction | 2025-11-20 | View → |
| 4 | Insider transaction | 2025-11-20 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $4.89
- Market Cap
- $621.32 million
- 52-Week Range
- $3.09 – $6.18
- Average Volume
- 838K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.